Hysterectomy for Cervical Cancer After Radiation
Author Information
Author(s): Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K
Primary Institution: Cancer Institute Hospital, Tokyo, Japan
Hypothesis
The study aims to determine the efficacy of adjuvant hysterectomy for treatment of residual disease in cervical carcinoma treated with radiation therapy.
Conclusion
Adjuvant hysterectomy is an effective addition to radiation therapy in the treatment of cervical cancer, even in patients with stage III disease and in those with non-squamous cell carcinoma.
Supporting Evidence
- The overall 5- and 10-year survival rates for patients who underwent hysterectomy were 68.6% and 65.7%, respectively.
- There was no significant difference in survival between patients with squamous cell carcinoma and those with non-squamous cell carcinoma.
- Patients with stage III disease showed a 5-year survival rate of 56.3% after hysterectomy.
Takeaway
This study found that removing the uterus after radiation can help some women with cervical cancer who still have disease left over.
Methodology
Retrospective study analyzing 1590 patients treated with radiation therapy, focusing on 35 patients who underwent hysterectomy for residual disease.
Potential Biases
Potential selection bias in choosing patients for hysterectomy.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Mean age of patients was 55.7 years, with a range of 36 to 74 years.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website